---
title: "Contineum Therapeutics, Inc. (CTNM.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CTNM.US.md"
symbol: "CTNM.US"
name: "Contineum Therapeutics, Inc."
industry: "Pharmaceuticals"
---

# Contineum Therapeutics, Inc. (CTNM.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [www.contineum-tx.com](https://www.contineum-tx.com) |

## Company Profile

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications with high unmet need in the United States. The company’s lead asset is PIPE-791, a novel, brain penetrant,...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -9.71 | 180/257 | - | - | - |
| PB | 3.19 | 114/257 | 1.98 | 1.62 | 0.60 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-09T05:00:00.000Z

Total Analysts: **7**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 5 | 71% |
| Overweight | 1 | 14% |
| Hold | 1 | 14% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 15.78 |
| Highest Target | 29.00 |
| Lowest Target | 14.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/CTNM.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CTNM.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CTNM.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.